Thought the yahoo conversation this a.m. is informative...additionally, spoke with our BMT physician today while we looked at our Cellpro selection device. He was on the original FDA panel looking at these things and knows the technology and the Isolex(R)300 system. Says the technology is correct, works, is evolving, and will continue over time. He agrees that if FDA approval is granted, this device would become a major factor in the marketplace. He feels that this is a long term situation and key is the FDA approval.
Bone Marrow Transplantation is evolving and becoming much more selective from a procedure standpoint...that is to say...as cell and gene therapy evolves, the portion (division) of the marrow which is selected for treatment becomes even more important, so stem cell selection devices will become more and more important and state of the art. Hope this information is helpful, as well as the yahoo thread. Regards, Bob
messages.yahoo.com@m2.yahoo.com |
